Dare Bioscience, Inc. (DARE)

NASDAQ: DARE · IEX Real-Time Price · USD
1.19
-0.04 (-3.25%)
At close: Jul 1, 2022 4:00 PM
1.18
-0.01 (-0.84%)
After-hours: Jul 1, 2022 7:09 PM EDT

Ratios and Metrics (Annual)

Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Current20212020201920182017201620152014
Market Capitalization
10115351148131977125
Market Cap Growth
-200.95%272.11%68.57%-37.98%-32.65%-74.63%-38.83%-
Enterprise Value
63102471016202177
PE Ratio
--3.96-1.86-0.91-0.48-1.14-28.88-1.93-5.36
PS Ratio
--------1.00
PB Ratio
3.263.95-44.2031.031.210.98-27.341.572.76
EV/Sales Ratio
--------891.57
Debt / Equity Ratio
0.040.01-0.661.820.000-0.980.420.07
Debt / EBITDA Ratio
-0.03-0.01-0.03-0.060.000-1.11-0.55-0.14
Debt / FCF Ratio
-0.04-0.01-0.03-0.060.000-1.87-0.63-0.16
Current Ratio
2.923.450.911.156.648.640.064.736.56
Asset Turnover
-00000000.00
Return on Equity (ROE)
-145.60%-189.60%-11098.30%-541.80%-151.00%-96.80%-3.50%-73.30%-159.30%
Return on Assets (ROA)
-94.30%-119.10%-322.50%-255.10%-137.40%-74.70%-1.80%-51.80%-48.90%
Return on Capital (ROIC)
-586.60%1139.80%2341.80%100.00%1265.60%-22.50%-434.60%14765.50%
Earnings Yield
-39.45%-25.26%-53.84%-110.04%-206.26%-87.90%-3.46%-51.71%-18.65%
FCF Yield
-32.49%-18.79%-49.61%-97.33%-126.68%-19.41%-1.92%-42.01%-15.38%
Buyback Yield / Dilution
-88.63%-103.23%-93.16%-45.16%-232.04%-287.10%67.17%-74.80%-2025.95%
Total Shareholder Return
-88.63%-103.23%-93.16%-45.16%-232.04%-287.10%67.17%-74.80%-2025.95%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).